The U.S. Securities and Exchange Commission (SEC) has issued interpretative guidance on the evolving use of company websites for dissemination of information.

Development of a well-designed corporate compliance program, to guard against anti-competitive actions, has long been considered a worthwhile endeavor for any corporation.

We’ve previously written about Motorola Mobility v. AU Optronics, currently pending in the Seventh Circuit.

Portions of a reverse payment suit against Endo Pharmaceuticals and others were recently dismissed by Judge William H. Orrick of the Northern District of California.

The intersection of IP and antitrust has always been fraught.

Trial is set for October 13th on an antitrust class action lawsuit alleging that Cox Communications used its monopoly power over premium cable services in Oklahoma City...

The current debate over whether Amazon holds the power of a monopolist or a monopsonist is likely to be narrowed to one question in a court room: What is the relevant product market that Amazon is allegedly dominating?

The New York Attorney General has issued guidance about the audit oversight requirements under the Non-Profit Revitalization Act.

In advance of an immediate trial or evidentiary hearing, the parties may request, if necessary, that the court direct limited expedited discovery targeting the factual issue to be tried.

Congress recently expanded eligibility for the Federal subsidy for continuation health coverage available under the American Recovery and Reinvestment Act of 2009 ("ARRA").

Under a recent amendment to the New York City Administrative Code, it is now unlawful to discriminate against job applicants based on their unemployment status.

The Supreme Court, in its decision in "United States v. Windsor", recently overturned Section 3 of the Federal Defense of Marriage Act.

The Biologics Price Competition and Innovation Act (BPCIA) provides for a series of disclosures between a biosimilar applicant and the innovator company, commonly referred to as the "patent dance."

The new draft document follows a previous draft Q&A document from February 2012 and a final document released in April 2015.

Well before the California Attorney General's power to enforce the California Consumer Privacy Act (CCPA) commenced on July 1, 2020, as we have recently reported, private plaintiffs had already jumped into the fray,

The Food and Drug Administration is stepping up its game with respect to the cybersecurity of medical devices.

The DOJ dealt United its latest regulatory blow on Tuesday after it filed suit to prevent United from renting 24 slots—Federal Aviation Administration takeoff and landing authorizations—at Newark Liberty International Airport.

After six weeks of trial and two days of deliberation, the jury has returned its verdict in favor of the defendants in In re: Nexium.

We have been following developments in People of the State of New York v. Actavis, the New York Attorney General's "product hopping" suit against Actavis and its subsidiary, Forest Laboratories LLC.

The court explicitly held that evidence of market manipulation by a dominant player in a commodities market could be enough to prove market power.